SCHEMBL9490893

SCHEMBL9490893

COC(=O)N(CC(N)=O)C(=O)c1c(F)ccc2c(C(F)(F)F)c(OC)ccc12

nearest known ligand 0.82

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
AKR1B10 O60218 1/20 0.42
AKR1A1 P14550 1/20 0.42
AKR1B1 P15121 1/20 0.42
GPBAR1 Q8TDU6 6/20 0.35
KCNN4 O15554 2/20 0.33
GAA P10253 1/20 0.33
CETP P11597 2/20 0.32
SMN1; SMN2 Q16637 2/20 0.31
MAPT P10636 1/20 0.31
RAB9A P51151 1/20 0.31
L3MBTL1 Q9Y468 1/20 0.31
CYP1A2 P05177 1/20 0.31
CYP2C9 P11712 1/20 0.31
CYP2C19 P33261 1/20 0.31
PDE4A P27815 1/20 0.31
PDE4B Q07343 1/20 0.31
PDE4C Q08493 1/20 0.31
PDE4D Q08499 1/20 0.31
SCN10A Q9Y5Y9 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9489016 0.90 AKR1B10 (0.50) AKR1B10AKR1A1AKR1B1KCNN4GAA
SCHEMBL9490493 0.85 AKR1B10 (0.49) AKR1B10AKR1A1AKR1B1GPBAR1GAA
SCHEMBL9489202 0.81 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1KCNN4CYP2C9
SCHEMBL9489492 0.80 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1GAACETP
SCHEMBL9489025 0.80 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1GAACETP
SCHEMBL9490632 0.79 AKR1B10 (0.58) AKR1B10AKR1A1AKR1B1GPBAR1GAA
SCHEMBL9491827 0.79 AKR1B10 (0.48) AKR1B10AKR1A1AKR1B1CETPCYP1A2
SCHEMBL10533165 0.78 AKR1B10 (0.39) AKR1B10AKR1A1AKR1B1KCNN4GAA
SCHEMBL9489702 0.77 AKR1B10 (0.61) AKR1B10AKR1A1AKR1B1GAAMAPT
SCHEMBL9491854 0.77 PTGS2 (0.40) AKR1B10AKR1A1AKR1B1PDE4APDE4B

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP claimed
WO-1989005793-A1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-29 WO claimed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP claimed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US claimed
EP-0322256-B1 N-ACYL-N-NAPHTHOYLGLYCINES AS ALDOSE REDUCTASE INHIBITORS AMERICAN HOME PRODUCTS CORPORATION (US) 1993-03-24 EP disclosed
EP-0322256-A1 N-acyl-N-naphthoylglycines as aldose reductase inhibitors AMERICAN HOME PRODUCTS CORPORATION (US) 1989-06-28 EP disclosed
US-4820727-A TREATING DIABETIC COMPLICATIONS-VISION DEFECTS, KIDNEY AND NERVOUS SYSTEM DISORDERS AMERICAN HOME PRODUCTS CORPORATION (US) 1989-04-11 US disclosed